Spot assays and gene expression analyses after tannic acid exposure. by Ming-Feng Lin (768243)

“…(B) The gene expression levels of the <i>baeR</i> and pump genes in the wild-type strain. At 50 μg/mL tannic acid, only <i>macB</i> showed a statistically significant increase in the wild-type strain. …”

Additional comparisons between testing strategies. by Lucia Cilloni (9720852)

“…Because a high-accuracy test is able to diagnose rifampicin resistance at the point of TB diagnosis, it can contribute strongly to long-term reductions in DR-TB incidence, thus also averting future costs of second-line treatment (<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1003456#pmed.1003456.g005" target="_blank">Fig 5B</a>). …”

datasheet1_Efficacy and Safety of Immunosuppressive Monotherapy Agents for IgA Nephropathy: A Network Meta-Analysis.docx by Shisheng Han (10019855)

“…<p>Background: The efficacy and safety of immunosuppressive monotherapy agents were evaluated for immunoglobulin A nephropathy (IgAN) using a network meta-analysis approach.…”

Forest plot. by Jiaxuan Wen (12531339)

“…Dexmedetomidine as opposed to midazolam achieved a shorter length of stay in ICU (MD = -2.25, 95%CI = -2.94, -1.57, p<0.0001), lower risk of delirium (RR = 0.63, 95%CI = 0.50, 0.81, p = 0.0002), and shorter duration of mechanical ventilation (MD = -0.83, 95%CI = -1.24, -0.43, p<0.0001). …”

Trial sequential analysis. by Jiaxuan Wen (12531339)

“…Dexmedetomidine as opposed to midazolam achieved a shorter length of stay in ICU (MD = -2.25, 95%CI = -2.94, -1.57, p<0.0001), lower risk of delirium (RR = 0.63, 95%CI = 0.50, 0.81, p = 0.0002), and shorter duration of mechanical ventilation (MD = -0.83, 95%CI = -1.24, -0.43, p<0.0001). …”

Characteristics of included studies. by Jiaxuan Wen (12531339)

“…Dexmedetomidine as opposed to midazolam achieved a shorter length of stay in ICU (MD = -2.25, 95%CI = -2.94, -1.57, p<0.0001), lower risk of delirium (RR = 0.63, 95%CI = 0.50, 0.81, p = 0.0002), and shorter duration of mechanical ventilation (MD = -0.83, 95%CI = -1.24, -0.43, p<0.0001). …”

Subgroup analysis. by Jiaxuan Wen (12531339)

“…Dexmedetomidine as opposed to midazolam achieved a shorter length of stay in ICU (MD = -2.25, 95%CI = -2.94, -1.57, p<0.0001), lower risk of delirium (RR = 0.63, 95%CI = 0.50, 0.81, p = 0.0002), and shorter duration of mechanical ventilation (MD = -0.83, 95%CI = -1.24, -0.43, p<0.0001). …”

Flow chart of the study selection process. by Jiaxuan Wen (12531339)

“…Dexmedetomidine as opposed to midazolam achieved a shorter length of stay in ICU (MD = -2.25, 95%CI = -2.94, -1.57, p<0.0001), lower risk of delirium (RR = 0.63, 95%CI = 0.50, 0.81, p = 0.0002), and shorter duration of mechanical ventilation (MD = -0.83, 95%CI = -1.24, -0.43, p<0.0001). …”

LY5 inhibits pSTAT3 in sarcoma cell lines. by Peter Y. Yu (4281448)

Estimated niche width for 11 native fish species in <i>Arapaima gigas</i> colonized and non-colonized lakes. by Danny Rejas (583637)

EG-specific MMP-1 RNAi does not block glial infiltration or pruning. by Vanessa Kay Miller (19775496)

Role of Oxygen Vacancy on the Hydrophobic Behavior of TiO₂ Nanorods on Chemically Etched Si Pyramids by C. P. Saini (3601670)

“…Apparent contact angle (CA) is found to increase from 122° to 141° up to a fluence of 1 × 10¹⁵ ions/cm², followed by a gradual reduction to 130° at 1 × 10¹⁷ ions/cm². …”

Role of Oxygen Vacancy on the Hydrophobic Behavior of TiO₂ Nanorods on Chemically Etched Si Pyramids by C. P. Saini (3601670)

“…Apparent contact angle (CA) is found to increase from 122° to 141° up to a fluence of 1 × 10¹⁵ ions/cm², followed by a gradual reduction to 130° at 1 × 10¹⁷ ions/cm². …”

Cell line characterization and combination effect of KRAS G12C inhibitors and pemigatinib. by Angela Abdollahi (15166230)

DataSheet1_Discovery of METTL3 Small Molecule Inhibitors by Virtual Screening of Natural Products.docx by Yue Du (588488)

“…The cellular assay of m⁶A methylation inhibition showed that quercetin decreased m⁶A level in a dose-dependent manner in MIA PaCa-2 pancreatic cancer cells. …”

Image_3_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.TIF by Mo Chen (299059)

Image_4_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.TIF by Mo Chen (299059)

Presentation_1_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.pdf by Mo Chen (299059)

Image_1_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.TIF by Mo Chen (299059)

Image_2_Bergenin as a Novel Urate-Lowering Therapeutic Strategy for Hyperuricemia.TIF by Mo Chen (299059)